|
PRPF38B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.37520000001545E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.19779999999226E-06 |
| Normal-vs-Stage2 |
3.760700E-03 |
| Normal-vs-Stage3 |
2.543500E-03 |
| Normal-vs-Stage4 |
9.240100E-03 |
| Stage1-vs-Stage2 |
9.087800E-01 |
| Stage1-vs-Stage3 |
2.876000E-01 |
| Stage1-vs-Stage4 |
2.463200E-01 |
| Stage2-vs-Stage3 |
4.140200E-01 |
| Stage2-vs-Stage4 |
3.458400E-01 |
| Stage3-vs-Stage4 |
8.376600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.86896999999631E-05 |
| Normal-vs-AfricanAmerican |
9.263800E-03 |
| Normal-vs-Asian |
2.033700E-02 |
| Caucasian-vs-AfricanAmerican |
7.041400E-01 |
| Caucasian-vs-Asian |
5.041800E-03 |
| AfricanAmerican-vs-Asian |
4.751900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.32630000000556E-05 |
| Normal-vs-Female |
1.17509999997267E-06 |
| Male-vs-Female |
1.677160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.186200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.44260000009855E-07 |
| Normal-vs-Age(61-80Yrs) |
3.625900E-04 |
| Normal-vs-Age(81-100Yrs) |
5.219000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.527000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.951800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.721600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.383800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.075700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.861400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.182280E-03 |
| Normal-vs-Grade 2 |
1.24299999959554E-07 |
| Normal-vs-Grade 3 |
3.102800E-03 |
| Normal-vs-Grade 4 |
3.131600E-02 |
| Grade 1-vs-Grade 2 |
6.274100E-02 |
| Grade 1-vs-Grade 3 |
6.807600E-04 |
| Grade 1-vs-Grade 4 |
5.520300E-03 |
| Grade 2-vs-Grade 3 |
3.463500E-03 |
| Grade 2-vs-Grade 4 |
5.409600E-02 |
| Grade 3-vs-Grade 4 |
9.820400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.81179998465831E-09 |
| Normal-vs-ccB subtype |
1.889600E-02 |
| ccA subtype-vs-ccB subtype |
2.577400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.51370000000584E-05 |
| Normal-vs-N1 |
3.493200E-01 |
| N0-vs-N1 |
6.751000E-01 |
|
|
